Diabetes Mellitus, Experimental
0.500
Biomarker
disease
CTD_human
Enalaprilat-mediated activation of kinin b(1) receptors and vasodilation in the rat isolated perfused kidney.
21430409
2011
Hyperalgesia
0.500
Biomarker
phenotype
CTD_human
Bradykinin receptor antagonists and cyclooxygenase inhibitors in vincristine- and streptozotocin-induced hyperalgesia.
19815945
2010
×
CUI:
C0030193
Disease:
Pain
Pain
0.500
Biomarker
phenotype
CTD_human
Kinin B1 receptors contributes to acute pain following minor surgery in humans.
20152050
2010
Hyperalgesia
0.500
Biomarker
phenotype
CTD_human
Bradykinin receptors antagonists and nitric oxide synthase inhibitors in vincristine and streptozotocin induced hyperalgesia in chemotherapy and diabetic neuropathy rat model.
19300402
2009
Diabetes Mellitus, Experimental
0.500
Biomarker
disease
RGD
Retinal plasma extravasation in streptozotocin-diabetic rats mediated by kinin B(1) and B(2) receptors.
18311190
2008
Hyperalgesia
0.500
Biomarker
phenotype
CTD_human
Effect of bradykinin receptor antagonists on vincristine- and streptozotocin-induced hyperalgesia in a rat model of chemotherapy-induced and diabetic neuropathy.
17989505
2008
×
CUI:
C0030193
Disease:
Pain
Pain
0.500
Biomarker
phenotype
RGD
Involvement of kinin B1 receptor and oxidative stress in sensory abnormalities and arterial hypertension in an experimental rat model of insulin resistance.
17988733
2007
Diabetes Mellitus, Experimental
0.500
Biomarker
disease
RGD
Up-regulation of kinin B1 receptor in the lung of streptozotocin-diabetic rat: autoradiographic and functional evidence.
12522068
2003
Hyperalgesia
0.500
Biomarker
phenotype
RGD
Therefore we have examined B1 bradykinin receptor regulation in rat dorsal root ganglia in a model of inflammatory hyperalgesia , and correlated it with hyperalgesic behaviour.
12927641
2003
Diabetes Mellitus, Experimental
0.500
Biomarker
disease
RGD
Regulation of cardiac bradykinin B1- and B2-receptor mRNA in experimental ischemic, diabetic, and pressure-overload-induced cardiomyopathy.
12489796
2002
Inflammation
0.310
Biomarker
phenotype
CTD_human
Kinin B1 receptors contributes to acute pain following minor surgery in humans.
20152050
2010
Inflammation
0.310
Biomarker
phenotype
LHGDN
Increased B(1)R gene and protein expression in active IBD provides a structural basis of the important role of bradykinin in chronic inflammation .
15805101
2005
Alloxan Diabetes
0.300
Biomarker
disease
CTD_human
Enalaprilat-mediated activation of kinin b(1) receptors and vasodilation in the rat isolated perfused kidney.
21430409
2011
Streptozotocin Diabetes
0.300
Biomarker
disease
CTD_human
Enalaprilat-mediated activation of kinin b(1) receptors and vasodilation in the rat isolated perfused kidney.
21430409
2011
Splenomegaly
0.300
Biomarker
phenotype
CTD_human
Myelopoiesis modulation by ACE hyperfunction in kinin B(1) receptor knockout mice: relationship with AcSDKP levels.
20096676
2010
Pain, Burning
0.300
Biomarker
phenotype
CTD_human
Kinin B1 receptors contributes to acute pain following minor surgery in humans.
20152050
2010
×
CUI:
C0234238
Disease:
Ache
Ache
0.300
Biomarker
phenotype
CTD_human
Kinin B1 receptors contributes to acute pain following minor surgery in humans.
20152050
2010
Radiating pain
0.300
Biomarker
phenotype
CTD_human
Kinin B1 receptors contributes to acute pain following minor surgery in humans.
20152050
2010
Allodynia
0.300
Biomarker
phenotype
CTD_human
Bradykinin receptor antagonists and cyclooxygenase inhibitors in vincristine- and streptozotocin-induced hyperalgesia.
19815945
2010
Pain, Splitting
0.300
Biomarker
phenotype
CTD_human
Kinin B1 receptors contributes to acute pain following minor surgery in humans.
20152050
2010
Pain, Crushing
0.300
Biomarker
phenotype
CTD_human
Kinin B1 receptors contributes to acute pain following minor surgery in humans.
20152050
2010
Hyperalgesia, Primary
0.300
Biomarker
phenotype
CTD_human
Bradykinin receptor antagonists and cyclooxygenase inhibitors in vincristine- and streptozotocin-induced hyperalgesia.
19815945
2010
Hyperalgesia, Secondary
0.300
Biomarker
phenotype
CTD_human
Bradykinin receptor antagonists and cyclooxygenase inhibitors in vincristine- and streptozotocin-induced hyperalgesia.
19815945
2010
Tactile Allodynia
0.300
Biomarker
phenotype
CTD_human
Bradykinin receptor antagonists and cyclooxygenase inhibitors in vincristine- and streptozotocin-induced hyperalgesia.
19815945
2010
Hyperalgesia, Thermal
0.300
Biomarker
phenotype
CTD_human
Bradykinin receptor antagonists and cyclooxygenase inhibitors in vincristine- and streptozotocin-induced hyperalgesia.
19815945
2010